Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

Doris K. Hansen

1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Lauren C. Peres

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Danai Dima

Fred Hutchinson Cancer Center, Seattle, Washington, United States

Alicia Richards

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States

Leyla Shune

Aimaz Afrough

Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center (A.A.), University of Texas Southwestern Medical Center, Dallas, TX.

Shonali Midha

13Dana-Farber Cancer Institute, Boston, United States

Binod Dhakal

2Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Mehmet H. Kocoglu

Shebli Atrash

Levine Cancer Institute–Atrium Health, Charlotte, NC

Christopher Ferreri

7Atrium Health Levine Cancer Institute, Charlotte, United States

Omar Castaneda

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

James A. Davis

13Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC

Evguenia Bhurtel

1The University of Kansas Cancer Center, Kansas City, United States

Joseph McGuirk

2The Mikael Rayaan Foundation Global Research Training Institute (MRF GRTI), Kansas City, United States

Charlotte Wagner

Radhika Bansal

4Division of Hematology, Mayo Clinic, Rochester, MN

Patrick Costello

9Division of Hematology, Dana-Farber Cancer Institute, Boston, MA

Kinaya Smith

4Medical College of Wisconsin, Milwaukee, United States

Alex Lieberman-Cribbin

12Icahn School of Medicine at Mount Sinai, New York, United States

Gabriel De Avila

H Lee Moffitt Cancer Center, Tampa, Florida, United States

Sneha Purvey

16Virginia Commonwealth University, Richmond, United States

Hitomi Hosoya

Lekha Mikkilineni

Stanford University School of Medicine, Palo Alto, California, United States

Laura B. Oswald

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Gurbakhash Kaur

Oren Pasvolsky

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Mahmoud Gaballa

4The University of Texas MD Anderson Cancer Center, Houston, United States

Megan M. Herr

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Peter Forsberg

7Colorado Blood Cancer Institute, Hematology, Denver, United States

Murali Janakiram

10City of Hope, Duarte, United States

Myo Htut

City of Hope, Duarte, California, United States

Sireesha Asoori Maringanti

UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA

Nilesh Kalariya

4The University of Texas MD Anderson Cancer Center, Houston, United States

Hamza Hashmi

Memorial Sloan Kettering Cancer Center, New York

Ran Reshef

13Division of Hematology/Oncology, Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY

Douglas W. Sborov

5Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT

Omar Nadeem

Faiz Anwer

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Jack Khouri

1Cleveland Clinic Foundation, Department of Hematology and Medical Oncology, Cleveland, United States

Shahzad Raza

Taussig Cancer Institute, Cleveland Clinic, Cleveland

Djordje Atanackovic

Melissa Alsina

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Ciara L. Freeman

7Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Frederick L. Locke

Peter Voorhees

Department of Materials Science and Engineering

Larry D. Anderson

1Myeloma, Waldenstrom’s, and Amyloidosis Program, Section of Hematologic Malignancies and Cellular Therapy, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX

Shambavi Richard

Icahn School of Medicine at Mount Sinai, New York

Thomas Martin

16Department of Hematology, University of California at San Francisco, San Francisco, CA

Yi Lin

Krina K. Patel

The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States

Surbhi Sidana

Stanford University School of Medicine, Palo Alto, CA